NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/16/2025
Back to search
Official data from USPTO
EDESA BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EDESA BIOTECH
ST13
US500000097414566Class
5
Filing
97414566
Registration
7950411
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
09/17/2025
Trademark type
Word
Nice classes
5
Filing date
05/17/2022
Registration date
09/16/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/16/2025
Last transaction
09/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
08/12/2024
First use in commerce
08/12/2024
Drawing code
4
Owner type
03
Owner location
Markham, Ontario, CA
Examiner
SHIH, SALLY
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Edesa Biotech, Inc.
Representatives
James M. Urzedowski FORSGREN FISHER MCCALMONT DEMAREA TYSVER LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for the treatment of inflammationimmune-related diseasesgastroenterological illnessesdermatological conditions and respiratory illnesses
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/16/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/03/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/28/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/18/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/15/2025
IUAF
USE AMENDMENT FILED
12/09/2024
EISU
TEAS STATEMENT OF USE RECEIVED
12/09/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2024
PUBO
PUBLISHED FOR OPPOSITION
10/15/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/16/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/08/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/08/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/08/2024
GNRT
NON-FINAL ACTION E-MAILED
02/08/2024
CNRT
NON-FINAL ACTION WRITTEN
02/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/12/2024
ALIE
ASSIGNED TO LIE
01/12/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/21/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/20/2023
GNSL
LETTER OF SUSPENSION E-MAILED
06/20/2023
CNSL
SUSPENSION LETTER WRITTEN
06/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/07/2023
GNRT
NON-FINAL ACTION E-MAILED
03/07/2023
CNRT
NON-FINAL ACTION WRITTEN
03/07/2023
DOCK
ASSIGNED TO EXAMINER
03/06/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/24/2022
NWAP
NEW APPLICATION ENTERED
05/20/2022
Continuous trademark protection
Get notified about every new filing that threatens EDESA BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.